Parallax Volatility Advisers, L.P. Cassava Sciences Inc Put Options Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	BUY	$16.33 - $51.06 $124,107 - $388,056	7,600 Added 11.43%	74,100 $3.1 Million
Q2 2022 Aug 15, 2022	BUY	$17.22 - $38.47 $737,016 - $1.65 Million	42,800 Added 180.59%	66,500 $1.87 Million
Q3 2021 Nov 15, 2021	BUY	$41.79 - $135.3 $125,370 - $405,900	3,000 Added 14.49%	23,700 $1.47 Million
Q2 2021 Aug 16, 2021	BUY	$32.15 - $89.72 $665,505 - $1.86 Million	20,700 New	20,700 $1.77 Million

201

13.9M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $110M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.